Axillary lymphoma is commonly associated with metastatic lymphoma, and the survival time of patients cannot be generalized. The most common type of axillary lymphoma is breast cancer with axillary lymph node metastasis, which usually has no significant effect with drug treatment, and patients are advised to take surgery in time. If patients can undergo modified radical breast cancer surgery and combine with chemotherapy or endocrine therapy after surgery, the effect is usually better and the 5-year survival rate of patients can reach about 90%. If the patient has axillary lymphoma combined with other distant metastases or cannot be treated surgically, the 5-year survival rate may be less than 10%. Patients found to have axillary lymphoma are recommended to visit oncology department in time, maintain positive treatment attitude and cooperate with doctors to help prolong survival period.